Market Tracker

05/22 5:16pm ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

8.04
Delayed Data
As of May 22
 -0.08 / -0.99%
Today’s Change
3.79
Today|||52-Week Range
9.45
+50.28%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close8.12
Today’s open8.06
Day’s range7.85 - 8.16
Volume234,423
Average volume (3 months)601,034
Market cap$618.2M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-14.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+79.73%
P/E ratioNM
Price/Sales218.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...+0.07+0.27%
--China Health Group I...-0.02-2.86%
OREXOrexigen Therapeutic...+0.01+0.20%
CORTCorcept Therapeutics...-0.04-0.68%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateFebruary 25, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.6M
Net profit margin-9,328.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts